SCHEMBL7265688

SCHEMBL7265688

CC(C)(C)NS(=O)(=O)c1sccc1B(O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 3/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 10/20 0.36
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
RECQL P46063 1/20 0.34
NSD2 O96028 2/20 0.34
MAPK1 P28482 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
PARG Q86W56 1/20 0.33
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6611523 0.79 PKM (0.33) LMNASMN1; SMN2TSHR
SCHEMBL10463947 0.77 ALDH1A1 (0.40) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL8645010 0.77 SMN1; SMN2 (0.40) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL10616070 0.76 NSD2 (0.46) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL19095461 0.72 MAPT (0.36) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL10465325 0.72 SMN1; SMN2 (0.36) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL9663862 0.72 ALDH1A1 (0.49) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL8642432 0.71 ALDH1A1 (0.36) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL8642688 0.71 GSK3B (0.40) LMNASMN1; SMN2KDM4EHPGDMAPT
SCHEMBL519774 0.70 NSD2 (0.47) LMNASMN1; SMN2KDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003064414-A1 TRICYCLIC COMPOUNDS USEFUL AS ANGIOTENSIN II AGONISTS VICORE PHARMA AB. (SE) 2003-08-07 WO disclosed